Related Experiment Video
Updated: Apr 15, 2026

Author Spotlight: Unveiling Mechanisms of Stress Resilience - Significant Findings, Advancements, and Future Research
Published on: December 15, 2023
Cardiovascular Risk Assessment and Effects on Behavior in Switzerland The Swiss Heart Foundation
Niclas Freund1, Bernhard C Friedli2, Therese Junker3
1University Hospital Basel, Cardiology Department, Switzerland.
Insights
CardioTest (®) in Swiss pharmacies identified cardiovascular risk and influenced behavior. While overall risk was low, higher risk scores prompted doctor consultations and correlated with increased cardiovascular events.
Area of Science:
- Cardiology
- Public Health
- Pharmacy Practice
Background:
- CardioTest (®) is a tool for assessing cardiovascular risk.
- The study evaluated its effectiveness in Swiss pharmacies for risk stratification and behavioral impact.
Purpose of the Study:
- To determine if pharmacy-based CardioTest (®) provides accurate cardiovascular risk stratification.
- To assess the impact of CardioTest (®) on individual behavior and lifestyle modifications.
Main Methods:
- Evaluated participants' blood pressure, waist circumference, blood samples, and risk factors.
- Calculated cardiovascular risk using the AGLA Risk Score (ARS), a modified PROCAM Score.
- Followed up participants after one year to assess actions taken and cardiovascular events (chest pain, myocardial infarction, stroke).
Main Results:
- 746 participants (mean age 62.7 years, 60% male) completed the follow-up.
- The majority had low cardiovascular risk (73.9% ARS <10%), with 21.7% intermediate and 4.4% high (ARS >20%).
- Higher ARS significantly correlated with increased doctor consultations and a higher rate of cardiovascular events.
Conclusions:
- Pharmacy-based CardioTest (®) offers risk stratification for future cardiovascular events.
- The tool appears to influence individual behavior and promote lifestyle changes.
- Consideration of alternative screening settings may be needed to reach higher-risk individuals earlier.
Background:
"CardioTest (®) " is a tool for cardiovascular risk assessment. The aim of this study was to evaluate if this test used in Swiss pharmacies provides risk stratification and if it had impact on individual behaviour.
Methods:
Individuals were evaluated (blood pressure, body waist circumference, random blood samples and coronary artery disease risk factors). The cardiovascular risk was calculated (AGLA Risk Score (ARS) a modified PROCAM Score) and participants were informed about their result. One year after the initial testing individuals were followed up by questionnaire with respect to the action they had taken based upon the ARS results. The relation between ARS results and events during follow-up were assessed. Events were defined as cardiovascular events due to chest pain, myocardial infarction or stroke.
Result:
A total of 1415 individuals were contacted for follow-up, 746 (53%) with a mean age of 62.7 (±12.8) years (60% were male) returned their questionnaire. The cardiovascular risk throughout the study-population turned out to be low: 73.9% had a low ARS <10%, 21.7% an intermediate ARS 10-20% and 4.4% had a high ARS >20%. Significantly more participants with ARS >20% consulted their family doctor (46.2%) than those with ARS 10-20% (25.2%) and ARS <10% (10.4%), respectively (p<0,01 for both comparisons). Sixty-four individuals (9%) suffered a cardiovascular event. The event rates increased as a function of ARS.
Conclusion:
The overall cardiovascular risk of individuals participating in a pharmacy based risk assessment program seems to be low. CardioTest (®) provided risk stratification with respect to future cardio-vascular events. CardioTest (®) seems to have impact on individual behavior and lifestyle modification. Other settings and locations for screening might be considered to reach higher risk individuals at an earlier stage.
Related Concept Videos
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Stress Prevention and Stress Management Techniques IV
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction

